|
|
|
|
|
|
Sponsored by: |
The Baruch Padeh Medical Center, Poriya |
Information provided by: | The Baruch Padeh Medical Center, Poriya |
ClinicalTrials.gov Identifier: | NCT00454038 |
The main purpose of this study is to investigate the efficacy of Hypro-Sorb® F, a bilayered bioabsorbable membrane in inducing bone regeneration in different dental procedures requiring GBR.
Condition | Intervention | Phase |
Cystectomy Segmental Growing of Alveolar Tissue Sinus Lift Root Amputation and Apicoectomy Periimplantitis |
Device: HYPRO SORB F |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Efficacy Study |
Official Title: | Preliminary Study of Hypro-Sorb® F Bilayer Bioabsorbable Membrane for Guided Tissue and Bone Regeneration |
Estimated Enrollment: | 100 |
Study Start Date: | June 2007 |
Estimated Study Completion Date: | May 2008 |
Guided bone regeneration is a procedure used in dentistry for the reconstruction of osseous defects around teeth, dental implants, and prior to implant placement. The main function of the membrane barrier in GBR is to mechanically prevent the undesirable penetration of epithelial cells and fibroblasts to the bone defect area, creating a secluded space where bone regeneration may occur. Resorbable and non-resorbable membranes have been used in GBR. While non resorbable membranes require another surgical procedure for removing the membrane after the healing period, the resorbable membranes have the advantage of transmitting tissue fluids, excluding undesirable cell penetration and sparing an additional unwanted surgical procedure. The aim of this study is to investigate the efficacy of Hypro-Sorb® F, a bilayered bioabsorbable membrane in inducing bone regeneration in different dental procedures requiring GBR.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Emad K Ailabouni, D.M.D | (972)46652429 | emadniss@netvision.net.il |
Contact: Rabab R Jarjoura, D.M.D | (972)504358785 | rababrj@yahoo.com |
Israel | |||||
The Baruch Padeh Medical Center, Poriya | |||||
Tiberias, Israel |
The Baruch Padeh Medical Center, Poriya |
Study Chair: | Alabuni Emad | The Baruch Padeh Medical Center |
Study ID Numbers: | ae-01.CTIL |
First Received: | March 28, 2007 |
Last Updated: | June 6, 2007 |
ClinicalTrials.gov Identifier: | NCT00454038 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|